Cargando…

What’s new in the management of adult bronchiectasis?

Bronchiectasis is a heterogeneous, chronic condition with many aetiologies. It poses a significant burden on patients and healthcare practitioners and services. Clinical exacerbations often result in reduced quality of life, increased rate of lung function decline, increased hospitalisation, and mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Koser, Usma, Hill, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399954/
https://www.ncbi.nlm.nih.gov/pubmed/28491293
http://dx.doi.org/10.12688/f1000research.10613.1
_version_ 1783230737354326016
author Koser, Usma
Hill, Adam
author_facet Koser, Usma
Hill, Adam
author_sort Koser, Usma
collection PubMed
description Bronchiectasis is a heterogeneous, chronic condition with many aetiologies. It poses a significant burden on patients and healthcare practitioners and services. Clinical exacerbations often result in reduced quality of life, increased rate of lung function decline, increased hospitalisation, and mortality. Recent focus in respiratory research, guidelines, and future management options has improved this clinical field in evidence-based practice, but further work and phase III clinical trials are required. This article aims to summarise and explore advances in management strategies in recent years and highlight areas of research and future focus.
format Online
Article
Text
id pubmed-5399954
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-53999542017-05-09 What’s new in the management of adult bronchiectasis? Koser, Usma Hill, Adam F1000Res Review Bronchiectasis is a heterogeneous, chronic condition with many aetiologies. It poses a significant burden on patients and healthcare practitioners and services. Clinical exacerbations often result in reduced quality of life, increased rate of lung function decline, increased hospitalisation, and mortality. Recent focus in respiratory research, guidelines, and future management options has improved this clinical field in evidence-based practice, but further work and phase III clinical trials are required. This article aims to summarise and explore advances in management strategies in recent years and highlight areas of research and future focus. F1000Research 2017-04-20 /pmc/articles/PMC5399954/ /pubmed/28491293 http://dx.doi.org/10.12688/f1000research.10613.1 Text en Copyright: © 2017 Koser U and Hill A http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Koser, Usma
Hill, Adam
What’s new in the management of adult bronchiectasis?
title What’s new in the management of adult bronchiectasis?
title_full What’s new in the management of adult bronchiectasis?
title_fullStr What’s new in the management of adult bronchiectasis?
title_full_unstemmed What’s new in the management of adult bronchiectasis?
title_short What’s new in the management of adult bronchiectasis?
title_sort what’s new in the management of adult bronchiectasis?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399954/
https://www.ncbi.nlm.nih.gov/pubmed/28491293
http://dx.doi.org/10.12688/f1000research.10613.1
work_keys_str_mv AT koserusma whatsnewinthemanagementofadultbronchiectasis
AT hilladam whatsnewinthemanagementofadultbronchiectasis